Merck/Medco firewall holding up
Executive Summary
Merck's Gilmartin professes ignorance about the Pharmaceutical Care Management Association's ads targeting chain drug stores in the Medicare debate (1"The Pink Sheet" June 16, 2003, p. 9). During his speech to the National Press Club, Gilmartin lamented the division of health care sectors into different "camps" in policy debates. When asked about the PCMA ads (funded in part by Merck's Medco Health PBM division), Gilmartin maintained that he is "unfamiliar" with the campaign...
You may also be interested in...
Formularies Would Be Authorized But Restricted Under Senate Medicare Bill
The Senate Finance Medicare drug coverage bill includes language dictating that beneficiaries cannot be forced to pay a higher copay for a non-formulary product if it is determined to be medically necessary
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.